A third option is suppression: the United States would forgo development of ASI and stop anyone else from building it on the basis that superintelligence is just too dangerous to be unleashed on the ...

Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an ...

Recursion, Roche, and its Genentech subsidiary have announced plans to co-develop a neuroscience discovery program based on ...

Recursion Pharmaceuticals reported mixed Q2 results, with revenue declining to $7.67 million. However, the company made significant strides in drug discovery and received FDA clearance for a new trial ...

A macOS ClickFix campaign shifted tactics from openly serving infostealer lures to hiding them behind a browser-fingerprinting gate. The change makes malicious infrastructure harder to detect while ...